BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3502194)

  • 1. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
    Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS
    Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the HLA association with rheumatoid arthritis.
    Woodrow JC
    Dis Markers; 1986 Jun; 4(1-2):7-12. PubMed ID: 3330699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
    Oren R; Laufer J; Goldberg I; Kopolovic J; Waldherr R; Passwell JH
    Immunology; 1995 Dec; 86(4):575-83. PubMed ID: 8567024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA frequency and haplotype analysis in a family study of adult onset rheumatoid arthritis.
    Colaco CB; Awad J; Festenstein H; Fielder A; Batchelor JR; Alonso A; McCloskey D; Shipley M; Corbett M; Roitt IM
    Dis Markers; 1986 Jun; 4(1-2):99-102. PubMed ID: 3502563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic aspects of hypertrophic cardiomyopathy (familial studies and relation of HLA to obstructive hypertrophic cardiomyopathy)].
    Moiseev VS; Polianskaia IS; Iazdovskiĭ VV; Korovina EP; Guniia MG
    Ter Arkh; 1987; 59(8):82-5. PubMed ID: 3500526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in 88 cases of rheumatic fever observed in Martinique.
    Monplaisir N; Valette I; Bach JF
    Tissue Antigens; 1986 Oct; 28(4):209-13. PubMed ID: 3492779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible haplotype association in Felty's syndrome.
    Klouda PT; Bidwell JL; Bodmer JG; Wasik A; Maddison PJ
    Dis Markers; 1986 Jun; 4(1-2):27-8. PubMed ID: 3502561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis.
    Katz J; Goultschin J; Benoliel R; Brautbar C
    J Periodontol; 1987 Sep; 58(9):607-10. PubMed ID: 3498813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA A-B and DR in dilated myocardiopathies].
    Komajda M; Raffoux C; Salame E; Colombani J; Grosgogeat Y; Cabrol C; Dausset J
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1233-7. PubMed ID: 3120659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
    Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
    J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial IgA nephropathy. Evidence of an inherited mechanism of disease.
    Julian BA; Quiggins PA; Thompson JS; Woodford SY; Gleason K; Wyatt RJ
    N Engl J Med; 1985 Jan; 312(4):202-8. PubMed ID: 3855328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the HLA system in rheumatoid arthritis].
    Minev M; Martinova F; Sheĭtanov I; Andreev T; Dimitrova D
    Vutr Boles; 1987; 26(3):72-5. PubMed ID: 3617709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of HLA in patients with glioma].
    Takai N; Yoshida S; Hara N; Saito T; Kamoya K; Tanaka R
    No To Shinkei; 1986 Aug; 38(8):741-5. PubMed ID: 3464315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A,B and DR antigens in chronic lymphocytic leukaemia.
    Dyer PA; Ridway JC; Flanagan NG
    Dis Markers; 1986 Oct; 4(3):231-7. PubMed ID: 3482989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lyme disease and HLA-DR antigens: relation between HLA-DR2 and HLA-DR4].
    Májský A; Bojar M; Jirous J
    Vnitr Lek; 1988 Jan; 34(1):54-9. PubMed ID: 3258452
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.
    Speirs C; Fielder AH; Chapel H; Davey NJ; Batchelor JR
    Lancet; 1989 Apr; 1(8644):922-4. PubMed ID: 2565418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The strong association of HLA-DR4 with spherical mesangial dense deposits in IgA nephropathy.
    Kohara M; Naito S; Arakawa K; Miyata J; Chihara J; Taguchi T; Takebayashi S
    J Clin Lab Immunol; 1985 Dec; 18(4):157-60. PubMed ID: 3879501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and IgA nephritis revisited 10 years later: HLA-B35 antigen as a prognostic factor.
    Berthoux FC; Alamartine E; Pommier G; Lepetit JC
    N Engl J Med; 1988 Dec; 319(24):1609-10. PubMed ID: 3264381
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of HLA-DR4 in the long-term prognosis of IgA nephropathy.
    Hiki Y; Kobayashi Y; Ookubo M; Kashiwagi N
    Nephron; 1990; 54(3):264-5. PubMed ID: 2314543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.